Business
ALR Technologies Releases New Website and Investor Presentation
ALR Technologies Releases New Website and Investor Presentation.
About this update from Alr Technologies Sg Ltd.
[{"type":"text","content":"\n SINGAPORE, Oct. 07, 2021 (GLOBE NEWSWIRE) -- ALR Technologies (“ALRT” or the “Company”) (OTCQB: ALRT), the diabetes management company, today announces that the Company has released a new investor presentation that can be viewed at www.alrt.com/investors. The Company invites investors and interested parties to explore the recently redesigned corporate website. “ALRT is at an inflection point, moving forward with high-level negotiations and due diligence processes that will be transformational to the fundamentals of our company. We want to ensure that our presentation and website concisely convey our strategic positioning in the human and animal diabetes markets as innovators of product, services, technology and big data,” commented Sidney Chan, Chairman and CEO at ALR Technologies. “Our team, which includes the key additions of Joe Stern as Head of Animal Health, Pete Riojas as Head of Global Commercial and Business Development, and Jacqueline Wu as Head of Corporate Marketing, looks forward to a consistent flow of announcements providing ALRT investors a transparent view of our developments over the coming weeks and months.” About ALR Technologies ALR Technologies is a data management company that developed the ALRT Diabetes Solution, a comprehensive approach to diabetes care that includes: an FDA-cleared and HIPAA compliant diabetes management system that collects data directly from blood glucose meters and continuous glucose monitoring devices; a patent pending Predictive A1C algorithm to track treatment success between lab reports and an FDA-cleared Insulin Dosing Adjustment program. ALRT also offers an algorithm to provide prescribers support for timely non-insulin medication advancements. The overall goal is to optimize diabetes drug therapies to drive improved patient outcomes. The program tracks performance of all clinical activities to ensure best practices are followed. The ALRT Diabetes Solution gives healthcare providers a platform for remote diabetes care, helping to minimize patient exposure to potential infections in clinical settings. Currently, the Company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data. In addition, the animal health division has identified an unmet need in diabetes care and has de...